Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16JOHNSTONE, Ricky W; WU WEI; GREENWAY, Alison et al.Oncogene (Basingstoke). 2000, Vol 19, Num 52, pp 6033-6042, issn 0950-9232Article

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsBAKER, Emma K; JOHNSTONE, Ricky W; ZALCBERG, John R et al.Oncogene (Basingstoke). 2005, Vol 24, Num 54, pp 8061-8075, issn 0950-9232, 15 p.Article

From cancer immunosurveillance to cancer immunotherapySTAGG, John; JOHNSTONE, Ricky W; SMYTH, Mark J et al.Immunological reviews. 2007, Vol 220, pp 82-101, issn 0105-2896, 20 p.Article

Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescenceHONG XIN; CURRY, Jonathan; JOHNSTONE, Ricky W et al.Oncogene (Basingstoke). 2003, Vol 22, Num 31, pp 4831-4840, issn 0950-9232, 10 p.Article

Deciphering the Molecular Events Necessary for Synergistic Tumor Cell Apoptosis Mediated by the Histone Deacetylase Inhibitor Vorinostat and the BH3 Mimetic ABT-737WIEGMANS, Adrian P; ALSOP, Amber E; JOHNSTONE, Ricky W et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 10, pp 3603-3615, issn 0008-5472, 13 p.Article

Novel mechanisms of apoptosis induced by histone deacetylase inhibitorsPEART, Melissa J; TAINTON, Kellie M; RUEFLI, Astrid A et al.Cancer research (Baltimore). 2003, Vol 63, Num 15, pp 4460-4471, issn 0008-5472, 12 p.Article

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacyCHESI, Marta; MATTHEWS, Geoffrey M; GARBITT, Victoria M et al.Blood. 2012, Vol 120, Num 2, pp 376-385, issn 0006-4971, 10 p.Article

Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsRUEFLI, Astrid A; BERNHARD, David; TAINTON, Kellie M et al.International journal of cancer. 2002, Vol 99, Num 2, pp 292-298, issn 0020-7136Article

E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesisWOLYNIEC, Kamil; SHORTT, Jake; JOHNSTONE, Ricky W et al.Blood. 2012, Vol 120, Num 4, pp 822-832, issn 0006-4971, 11 p.Article

Antitumor activities and on-target toxicities mediated by a TRAIL receptor agonist following cotreatment with panobinostatMARTIN, Ben P; FREW, Ailsa J; BOTS, Michael et al.International journal of cancer (Print). 2011, Vol 128, Num 11, pp 2735-2747, issn 0020-7136, 13 p.Article

A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathwayAGLIPAY, Jason A; LEE, Sam W; OUCHI, Toru et al.Oncogene (Basingstoke). 2003, Vol 22, Num 55, pp 8931-8938, issn 0950-9232, 8 p.Article

Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitorsSHEPPARD, Karen E; CULLINANE, Carleen; ELLUL, Jason et al.European journal of cancer (1990). 2013, Vol 49, Num 18, pp 3936-3944, issn 0959-8049, 9 p.Article

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor―induced thrombocytopeniaBISHTON, Mark J; HARRISON, Simon J; MARTIN, Benjamin P et al.Blood. 2011, Vol 117, Num 13, pp 3658-3668, issn 0006-4971, 11 p.Article

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyELLIS, Leigh; BOTS, Michael; JOHNSTONE, Ricky W et al.Blood. 2009, Vol 114, Num 2, pp 380-393, issn 0006-4971, 14 p.Article

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory AntibodiesVERBRUGGE, Inge; HAGEKYRIAKOU, Jim; HAYNES, Nicole M et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 13, pp 3163-3174, issn 0008-5472, 12 p.Article

Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemiaCRAZZOLARA, Roman; JÖHRER, Karin; JOHNSTONE, Ricky W et al.British journal of haematology. 2002, Vol 119, Num 4, pp 965-969, issn 0007-1048, 5 p.Article

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaMATTAROLLO, Stephen R; WEST, Alison C; BOTS, Michael et al.Blood. 2012, Vol 120, Num 15, pp 3019-3029, issn 0006-4971, 11 p.Article

Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsWHITECROSS, Kate F; ALSOP, Amber E; CLUSE, Leonie A et al.Blood. 2009, Vol 113, Num 9, pp 1982-1991, issn 0006-4971, 10 p.Article

Dissecting the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer therapiesRUEFLI, Astrid A; DAVIS, Joanne E; SUTTON, Vivien R et al.Drug development research. 2001, Vol 52, Num 4, pp 549-557, issn 0272-4391Article